September 24, 2013
Researchers at the National Heart and Lung Institute (NHLI) at Imperial College London (ICL) have announced they are closer to a universal flu vaccine that would include those who are resistant to severe illnesses.
Funding for this study was provided by the Imperial College Healthcare National Health Service (NHS) Trust, the National Institutes of Health (NIH), the Medical Research Council (MRC) and Public Health England (PHE).
By analyzing blood samples donated by 300 staff and student volunteers at the time the swine flu was beginning to emerge, the team at ICL discovered that those who are able to avoid contracting illness have more CD8 T cells , a virus-killing immune cell found in the blood.
Ajit Lalvani, professor for the NHLI and lead author of the study stated: “New strains of flu are continuously emerging, some of which are deadly, and so the Holy Grail is to create a universal vaccine that would be effective against all strains of flu.”
Current flu vaccines are designed to interact with the immune system. Lalvani’s team has discovered that T cells protect against flu symptoms.
Lalvani explained: “The immune system produces these CD8 T cells in response to usual seasonal flu. Unlike antibodies, they target the core of the virus, which doesn’t change, even in new pandemic strains. The 2009 pandemic provided a unique natural experiment to test whether T cells could recognize, and protect us against, new strains that we haven’t encountered before and to which we lack antibodies. Our findings suggest that by making the body produce more of this specific type of CD8 T cell, you can protect people against symptomatic illness. This provides the blueprint for developing a universal flu vaccine. We already know how to stimulate the immune system to make CD8 T cells by vaccination. Now that we know these T cells may protect, we can design a vaccine to prevent people getting symptoms and transmitting infection to others. This could curb seasonal flu annually and protect people against future pandemics.”
In 2012, the University of British Columbia (UBC) conducted a study to determine the viability of developing a universal vaccine.
The issue then was the human immune system (HIS) and how to stimulate it to act as researchers want – specifically to direct antibodies to circulate in the bloodstream and kill pre-determined germs.
Richard Pebody, responsible for flu surveillance in the Respiratory Diseases Department (RDD) at PHE said : “Influenza is continually evolving and it is difficult to predict what strains will emerge each year. These findings contribute to the science to determine if it is possible to develop a universal vaccine to protect a population against all strains of flu. The study results are a timely reminder for people to get their flu jab this winter.”
Wayne Madsen, former National Security Agency (NSA) official, asserts that the 2009 swine flu was genetically engineered with a mixture of human, bird and pig viruses to create an effective bioweapon.
Madsen explained: “A top scientist for the United Nations, who has examined the outbreak of the deadly Ebola virus in Africa, as well as HIV/AIDS victims, concluded that H1N1 possesses certain transmission vectors that suggest that the new flu strain has been genetically-manufactured as a military biological warfare weapon.”
Madsen said that his sources “are convinced that the current outbreak of a new strain of swine flu in Mexico and some parts of the United States is the result of the introduction of a human-engineered pathogen that could result in a widespread global pandemic, with potentially catastrophic consequences for domestic and international travel and commerce.”
Anonymous sources who “spoke with top officials at the UN” and the World Health Organization (WHO) state that the swine flu that appeared in Mexico was “the result of an artificially created pathogen.”
UN scientists “discovered certain joint transmission vectors, that is, the transmission of the swine flu virus is similar to the transmission of the Ebola virus and of the HIV/AIDS virus, which indicates that they were genetically modified with the aim of being military bio-weapons.”
Indeed the A-H1N1 virus contains “partly contains American pig genes, partly human and bird flu strains and the virus of the Euro-Asian swine flu.”
Other reports contend that in 2009, Bayer International (BI) “accidentally” delivered vaccine material “contaminated with live Avian bird flu and seasonal influenza to multiple laboratories” across the globe.
BI is the same corporation that sold HIV tainted blood plasma that resulted in thousands of hemophiliac patients being subjected to exposure to the HIV virus.
BI continued to knowingly sell this plasma “to get rid of the inventory” because “the company hoped to preserve the profit margin from ‘several large fixed-price contracts.’”